Eyconis

Therapeutic Devices · Redwood City, CA · Founded 2023 · Privately Held (backing)

Developer of ophthalmology products designed to improve ophthalmology treatments. Eyconis is based in Redwood City, CA and was founded in 2023. Its last reported valuation was $161 million in Jan 2024. It has raised $85.3 million across 2 recorded rounds; the latest was a $25 million early-stage round in Oct 2025.

Last reported valuation
$160.5M
Oct 2026
Priced at
—
Total raised
$85.3M
Last round
Early Stage VC
Oct 2025
What is Eyconis worth?
$160.5Mlast reported valuation · Oct 2026

Eyconis's last reported valuation, Jan 2024. Nothing priced has surfaced since.

Free account
More of Eyconis with a free account
  • ·Watch Eyconis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Eyconis funding history

2 rounds
DateRoundRaisedPost-money
Oct 2025Early Stage VC$25.0M▮
Jan 2024Early Stage VC (Series A)$60.3M▮
Unlock post-money valuations

Membership and data by Private Market View

Eyconis valuation

Eyconis's last reported valuation was $161 million in Jan 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Eyconis raised?

Eyconis has raised $85.3 million across 2 recorded rounds since 2024. The largest was a $60.3 million Series A in Jan 2024; the most recent was a $25 million early-stage round in Oct 2025.

Eyconis has filed 1 Form D with the SEC, most recently in Feb 2024 ($60.3 million sold to 7 investors).

Comparable companies

Comparable therapeutic devices names by valuation on PrivateMarketView: Soufflé Therapeutics ($345 million), Galvanize Therapeutics ($300 million) and Materna Medical ($110 million).

How Eyconis's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Eyconis, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Eyconis

What is Eyconis worth?
Eyconis is valued at $160.5M as of Oct 2026. Eyconis's last reported valuation, Jan 2024. Nothing priced has surfaced since.
How much has Eyconis raised?
Eyconis has raised $85.3M in total funding across 2 recorded rounds.
When did Eyconis last raise?
Eyconis last raised in Oct 2025 (Early Stage VC), raising $25.0M.